Quinn was founded by Daniel Gomari, Michael Snyder in 2022.

Who are Quinn's investors?

Quinn's investors include Y Combinator.

Where is Quinn headquartered?

Quinn is headquartered in San Francisco, US.

Quinn

San Francisco, US · Founded 2022 · 5 employees · Hiring · 1 known investors

Find your way into Quinn

906 people in our graph share verified history with the Quinn team — schools, employers, funds. One of them is your warm intro.

Paul Kwanunlockedknows Daniel Gomari · together at Stanford University (overlapped)

×4knows the team · via Ludwig-Maximilians-Universität München

×3knows the team · via Cornell

×3knows the team · via Stanford University

knows the team · via Technical University of Munich

Quinn is an AI research service that synthesizes biological, clinical, and competitive evidence from published literature and databases to answer drug development questions for biotech companies. It delivers structured, traceable evidence packages for decisions across target validation, indication prioritization, biomarker strategy, and trial design.

Also known as iollo

AI & Machine Learning Biotech Deep Tech Healthtech Artificial Intelligence Generative AI EnterpriseUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S22)

Quinn was founded in 2022 by Daniel Gomari and Michael Snyder.

Daniel Gomari in 𝕏Founder and CEODaniel Gomari holds a PhD in Computational Biology and completed a postdoctoral fellowship at Stanford, where he conducted research on machine learning applications in drug repurposing for cancer and metabolic disease, and multi-omics studies on aging. He founded Quinn to address pharmaceutical R&D processes.

Michael SnyderCo-founder, PhD, Chair of Genetics at Stanford

Investors · 1

Y Combinator✓ verifiedSan Francisco · $500K

In the news

Toppan Merrill expands Quinn platform to simplify shareholder communications drafting, filing and distribution - AOLaol.com · Jul 2026

🌳 iollo - Live Healthier and Much Longerycombinator.com · Jul 2022

Frequently asked questions

What does Quinn do?: Quinn is an AI research service that synthesizes biological, clinical, and competitive evidence from published literature and databases to answer drug development questions for biotech companies. It delivers structured, traceable evidence packages for decisions across target validation, indication prioritization, biomarker strategy, and trial design.
Who founded Quinn?: Quinn was founded by Daniel Gomari, Michael Snyder in 2022.
Who are Quinn's investors?: Quinn's investors include Y Combinator.
Where is Quinn headquartered?: Quinn is headquartered in San Francisco, US.